| Financial Year |
March 31 2023 |
| Monetary Funds |
14,611,055,370.16 |
| Held-for-trading Financial Assets |
3,787,090,745.06 |
| Notes Receivable |
340,815,023.18 |
| Accounts Receivable |
10,106,629,697.83 |
| Advances to Suppliers |
35,351,752,118.22 |
| Other Receivables |
4,124,831,643.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
46,255,509,616.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
731,205,408.64 |
| Other Current Assets |
8,516,285,835.25 |
| Total Current Assets |
125,844,078,388.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
948,157,790.13 |
| Long-term Equity Investment |
8,003,586,554.76 |
| Investment Properties |
1,745,803,962.15 |
| Fixed Assetes |
4,479,405,908.95 |
| Under-construction Projects |
614,852,531.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
314,724,406.11 |
| R&D expenses |
-- |
| Goodwill |
691,453.31 |
| Long-Term Deferred and Prepaid Expenses |
32,515,204.05 |
| Deferred Income Tax Assets |
1,575,711,233.05 |
| Other Non-Current Assets |
30,784,880.37 |
| Sub-Total of Non-Current Assets |
19,348,834,908.24 |
| Total Assets |
145,192,913,296.40 |
| Short-Term Loans |
32,634,157,325.66 |
| Trading Financial liabilities |
8,595,832.69 |
| Notes Payable |
20,481,545,755.46 |
| Accounts Payable |
6,987,713,125.29 |
| Accounts Received In Advance |
34,009,326.96 |
| Employee Compensation Payable |
1,089,668,894.15 |
| Taxes Payable |
850,167,553.71 |
| Interest Payable |
-- |
| Dividend Payable |
67,142,697.88 |
| Other payables |
1,979,101,133.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,455,170,123.74 |
| Other Current Liabilities |
18,038,394,921.39 |
| Sub-Total of Current Liabilities |
103,144,249,042.21 |
| Long-term Loans |
2,569,618,970.36 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
69,553,893.48 |
| Special Payable |
-- |
| Estimatied Liabilities |
83,487,955.62 |
| Deferred Income Tax Liabilities |
419,971,800.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,323,236,632.11 |
| Total Liabilities |
106,467,485,674.32 |
| Paid-In Capital(Or Share Stock) |
2,200,982,757.00 |
| Capital Surplus |
4,741,762,282.00 |
| Surplus Reserve |
1,136,014,090.81 |
| LESS:Treasury Stock |
416,654,722.50 |
| Undistributed Profits |
13,944,171,809.41 |
| Minority Stockholder's Interest |
7,863,728,687.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
30,861,698,934.87 |
| Owner's Equity（Stockholder's Equity） |
38,725,427,622.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
145,192,913,296.40 |
